Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb;24(2):119-29.
doi: 10.2165/11310940-000000000-00000.

Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease

Affiliations
Review

Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease

Angelo Antonini et al. CNS Drugs. 2010 Feb.

Abstract

Levodopa is the most effective treatment for Parkinson's disease (PD) signs and symptoms, and patients invariably will require it during the course of the disease. It also provides benefits in activities of daily living, quality of life and life expectancy. However, after a few years of levodopa treatment the majority of patients will experience motor fluctuations and dyskinesia. Initial use of a dopamine receptor agonist may delay the emergence of motor fluctuations but at the cost of reduced symptomatic control compared with the use of levodopa in some cases. Adequate management of motor fluctuations and dyskinesia is essential to maintaining satisfactory quality of life at the advanced stage of disease. Various levodopa-based strategies are currently available that aim to control motor complications (wearing-off and dyskinesia) in PD and each approach has its own unique benefit and risk profile. Strategies such as dose fragmentation (smaller, more frequent dosing) or the use of orally administered, liquid levodopa formulations or melevodopa can reduce off-time intervals or facilitate absorption. More recently introduced, continuous delivery of dopaminergic medications may represent a more effective approach to treat motor complications in advanced PD and its effect can be perceived from improvement in clinical scales, as well as in health-related items. Indeed, continuous levodopa delivery by duodenal infusion may stabilize and significantly improve motor function as well as patients' quality of life. We propose a treatment algorithm that takes into account all currently available levodopa-based treatment strategies for motor complications in patients with PD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurosci Lett. 2005 Mar 3;375(3):170-3 - PubMed
    1. Brain. 1984 Jun;107 ( Pt 2):487-506 - PubMed
    1. Parkinsonism Relat Disord. 2001 Oct;8(2):95-100 - PubMed
    1. Neurology. 2005 Jan 25;64(2):216-23 - PubMed
    1. J Pharmacol Exp Ther. 1975 Dec;195(3):453-64 - PubMed

MeSH terms

LinkOut - more resources